Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01007058 · ClinicalTrials.gov registry record
Markers of Response to Intravesical Bladder Cancer Therapy
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 150
- Enrollment target
NCT01007058: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01007058 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01007058 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The goal of this laboratory research study is to see if researchers can predict whose cancer will stay in remission and whose will return in patients receiving treatment for bladder cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2005-06 |
| Est. Completion | 2016-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01007058
The ClinicalTrials.gov registry entry for NCT01007058 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01007058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01007058 about?
NCT01007058 is a clinical study titled "Markers of Response to Intravesical Bladder Cancer Therapy". The goal of this laboratory research study is to see if researchers can predict whose cancer will stay in remission and whose will return in patients receiving treatment for bladder cancer.
What is the current status of trial NCT01007058?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2005-06. Estimated completion is 2016-04.
Who is sponsoring clinical trial NCT01007058?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.